Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Amortization of Deferred Charges (2023)

iBio (IBIO) has disclosed Amortization of Deferred Charges for 1 consecutive years, with $30000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Amortization of Deferred Charges changed N/A to $30000.0 in Q4 2023 year-over-year; TTM through Jun 2024 was $120000.0, a N/A change, with the full-year FY2024 number at $120000.0, down 50.41% from a year prior.
  • Amortization of Deferred Charges was $30000.0 for Q4 2023 at iBio, down from $90000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $90000.0 in Q3 2023 to a low of $30000.0 in Q4 2023.